Last 12 months
Inside the activity.
0 purchase rows · 142 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 32 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 31 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 23 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 26 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
Exercise / conversionCommon Stock | 2,521 | $52.26 | $131,747.46 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · nonDerivative · entry 6 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $105.00 per share. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $52.26 | $0.00 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · derivative · entry 19 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires 2030-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $95.00 per share. F12 · derivative.exercise_date: 50,000 options were granted that vest in four equal annual installments beginning on January 21, 2021. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $52.26 | $0.00 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · derivative · entry 18 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires 2030-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $95.00 per share. F12 · derivative.exercise_date: 50,000 options were granted that vest in four equal annual installments beginning on January 21, 2021. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
SaleCommon Stock | 3,428 | $95.08 | $325,936.98 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · nonDerivative · entry 5 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,556 F3 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates sales of 3,428 shares with a limit price of $95.00 per share. F2 · price: The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
SaleCommon Stock | 12,500 | $95.04 | $1,188,061.25 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · nonDerivative · entry 4 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,984 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $95.00 per share. F2 · price: The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
Exercise / conversionCommon Stock | 12,500 | $52.26 | $653,250.00 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · nonDerivative · entry 3 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $95.00 per share. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
SaleCommon Stock | 12,500 | $95.05 | $1,188,125.00 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · nonDerivative · entry 2 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,984 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $95.00 per share. F2 · price: The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 19, 2023 Filed May 23, 2023 16:23 UTC |
ROMANO KATHRYNChief Accounting Officer
|
Exercise / conversionCommon Stock | 12,500 | $52.26 | $653,250.00 |
DisclosureSEC source: 0001801385-23-000004 · wf-form4_168487338437565.xml · nonDerivative · entry 1 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on January 16, 2023 and will terminate on January 16, 2024 and contemplates option exercises and sales of 12,500 shares with a limit price of $95.00 per share. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:20 UTC |
JANNEY DANIELDirector
|
SaleCommon Stock | 50,000 | $95.02 | $4,751,185.00 |
DisclosureSEC source: 0001711279-23-000042 · wf-form4_168487321853185.xml · nonDerivative · entry 1 JANNEY DANIEL · CIK 0001198325 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Directly beneficially owned by Alta Bioequities, L.P. Disclosed balance after: 157,362 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 12, 2022 and will terminate on September 11, 2023 and contemplates sales of 50,000 shares with a limit price of $95.00 per share. F2 · price: The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. The Reporting Person is the Managing Director of Alta Bioequities Management, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:30 UTC |
JANNEY DANIELDirector
|
SaleCommon Stock | 17,100 | $90.74 | $1,551,578.76 |
DisclosureSEC source: 0001711279-23-000035 · wf-form4_168383702435561.xml · nonDerivative · entry 1 JANNEY DANIEL · CIK 0001198325 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Directly beneficially owned by Alta Bioequities, L.P. Disclosed balance after: 207,362 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 12, 2022 and will terminate on September 11, 2023 and contemplates sales of 25,000 shares with a limit price of $90.00 per share. F2 · price: The transaction was executed in multiple trades ranging from $90.0000 to $91.1350. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. The Reporting Person is the Managing Director of Alta Bioequities Management, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 20:10 UTC |
JANNEY DANIELDirector
|
SaleCommon Stock | 7,900 | $90.32 | $713,493.24 |
DisclosureSEC source: 0001711279-23-000023 · wf-form4_168210784238261.xml · nonDerivative · entry 1 JANNEY DANIEL · CIK 0001198325 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Directly beneficially owned by Alta Bioequities, L.P. Disclosed balance after: 224,462 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 12, 2022 and will terminate on September 11, 2023 and contemplates sales of 25,000 shares with a limit price of $90.00 per share. F2 · price: The transaction was executed in multiple trades ranging from $90.0000 to $90.3650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. The Reporting Person is the Managing Director of Alta Bioequities Management, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 500 | $89.12 | $44,558.75 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 10 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,652,263 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F6 · price: The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 9,724 | $88.41 | $859,661.89 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 9 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,652,763 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F5 · price: The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 9,429 | $87.41 | $824,202.09 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 8 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,662,487 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F4 · price: The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 4,297 | $86.80 | $372,964.13 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 7 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,671,916 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F3 · price: The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 1,050 | $85.55 | $89,826.14 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 6 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,676,213 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F2 · price: The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 500 | $89.12 | $44,558.75 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 5 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,709,338 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F6 · price: The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 9,724 | $88.41 | $859,661.89 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 4 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,709,838 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F5 · price: The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 9,428 | $87.41 | $824,113.74 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 3 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,719,562 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F4 · price: The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 4,298 | $86.80 | $373,050.93 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 2 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,728,990 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F3 · price: The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:06 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 1,050 | $85.55 | $89,825.72 |
DisclosureSEC source: 0001298709-23-000015 · wf-form4_168184839404028.xml · nonDerivative · entry 1 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,733,288 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F2 · price: The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 500 | $89.12 | $44,558.75 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 10 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,713,688 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F6 · price: The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 9,724 | $88.41 | $859,661.89 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 9 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,714,188 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F5 · price: The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 9,428 | $87.41 | $824,113.74 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 8 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,723,912 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F4 · price: The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 4,298 | $86.80 | $373,050.93 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 7 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,733,340 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F3 · price: The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 1,050 | $85.55 | $89,825.72 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 6 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 1,737,638 F7 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F8 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F2 · price: The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F9 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 500 | $89.12 | $44,558.75 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 5 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,649,206 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F6 · price: The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 9,724 | $88.41 | $859,661.89 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 4 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,649,706 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F5 · price: The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 9,429 | $87.41 | $824,202.09 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 3 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,659,430 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F4 · price: The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 4,297 | $86.80 | $372,964.13 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 2 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,668,859 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F3 · price: The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:08 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 1,050 | $85.55 | $89,826.14 |
DisclosureSEC source: 0001298711-23-000012 · wf-form4_168184848206201.xml · nonDerivative · entry 1 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,673,156 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and contemplated quarterly sales of 25,000 shares with a limit price of $80.00 per share. The Rule 10b5-1 trading plan has now reached the maximum number of shares to be sold under such plan. F2 · price: The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:05 UTC |
Mazzacco CatherineDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,600 | $0.00 Strike: $80.06 | $0.00 |
DisclosureSEC source: 0001967722-23-000007 · wf-form4_168064231771350.xml · derivative · entry 1 Mazzacco Catherine · CIK 0001967722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,600 Underlying: Common Stock · 13,600 shares Expires 2033-03-31 F1 · derivative.exercise_date: The options were awarded on March 31, 2023 and vest in equal monthly tranches over a three-year period. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:05 UTC |
ROSSI DINO ADirector
|
SaleCommon Stock | 40,000 | $83.25 | $3,329,972.00 |
DisclosureSEC source: 0001711279-23-000012 · wf-form4_167779471000119.xml · nonDerivative · entry 1 ROSSI DINO A · CIK 0001209059 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,691 F1 · price: The transaction was executed in multiple trades ranging from $82.245 to $83.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 18:45 UTC |
ORTH ANDREW C.Chief Commercial Officer
|
GrantPerformance Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001860010-23-000002 · wf-form4_167762789935314.xml · derivative · entry 3 ORTH ANDREW C. · CIK 0001860010 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. F3 · shares: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. F4 · derivative.exercise_date: If any applicable portion of the performance criteria have been achieved, the award shall vest in two equal annual installments (February 28, 2024 and February 28, 2025). F5 · derivative.expiration_date: If the performance criteria are not achieved, the portion of the award which was capable of vesting on that date will expire. F3 · derivative.underlying_shares: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. F3 · balance_after: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 18:45 UTC |
ORTH ANDREW C.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $81.91 | $0.00 |
DisclosureSEC source: 0001860010-23-000002 · wf-form4_167762789935314.xml · derivative · entry 2 ORTH ANDREW C. · CIK 0001860010 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2024. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 18:43 UTC |
ROMANO KATHRYNChief Accounting Officer
|
GrantPerformance Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001801385-23-000002 · wf-form4_167762777317914.xml · derivative · entry 3 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. F5 · shares: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance metrics set by the Company's Compensation Committee for this award. F6 · derivative.exercise_date: If any applicable portion of the performance criteria have been achieved, the award shall vest in two equal annual installments (February 28, 2024 and February 28, 2025). F7 · derivative.expiration_date: If the performance criteria are not achieved, the portion of the award which was capable of vesting on that date will expire. F5 · derivative.underlying_shares: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance metrics set by the Company's Compensation Committee for this award. F5 · balance_after: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance metrics set by the Company's Compensation Committee for this award. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 18:43 UTC |
ROMANO KATHRYNChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $81.91 | $0.00 |
DisclosureSEC source: 0001801385-23-000002 · wf-form4_167762777317914.xml · derivative · entry 2 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-02-28 F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2024. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 23:41 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
GrantPerformance Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001298711-23-000010 · wf-form4_167762766195597.xml · derivative · entry 6 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain corporate performance criteria during the year ended December 31, 2023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. F7 · shares: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. F8 · derivative.exercise_date: If any applicable portion of the performance criteria have been achieved, the award shall vest in two equal annual installments (February 28, 2024 and February 28, 2025). F9 · derivative.expiration_date: If the performance criteria are not achieved, the portion of the award which was capable of vesting on that date will expire. F7 · derivative.underlying_shares: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. F7 · balance_after: The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 23:41 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $81.91 | $0.00 |
DisclosureSEC source: 0001298711-23-000010 · wf-form4_167762766195597.xml · derivative · entry 5 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-02-28 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2024. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 23:39 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
GrantPerformance Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001298709-23-000013 · wf-form4_167762753740439.xml · derivative · entry 6 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain corporate performance criteria during the year ended December 31, 2023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. F7 · shares: The number of PSUs in this column represents the number of shares of common stock the reporting person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. F8 · derivative.exercise_date: If any applicable portion of the performance criteria have been achieved, the award shall vest in two equal annual installments (February 28, 2024 and February 28, 2025). F9 · derivative.expiration_date: If the performance criteria are not achieved, the portion of the award which was capable of vesting on that date will expire. F7 · derivative.underlying_shares: The number of PSUs in this column represents the number of shares of common stock the reporting person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. F7 · balance_after: The number of PSUs in this column represents the number of shares of common stock the reporting person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 23:39 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $81.91 Strike: $81.91 | $4,095,500.00 |
DisclosureSEC source: 0001298709-23-000013 · wf-form4_167762753740439.xml · derivative · entry 5 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-02-28 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2024. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 18:43 UTC |
ROMANO KATHRYNChief Accounting Officer
|
Tax withholdingCommon Stock | 2,144 | $78.46 | $168,218.24 |
DisclosureSEC source: 0001801385-23-000002 · wf-form4_167762777317914.xml · nonDerivative · entry 1 Romano Kathryn · CIK 0001801385 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,984 F1 · shares: Represents tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2023. F2 · price: The closing price on February 24, 2023 of the Company's common stock on NASDAQ. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 23:41 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
Tax withholdingCommon Stock | 3,057 | $78.46 | $239,852.22 |
DisclosureSEC source: 0001298711-23-000010 · wf-form4_167762766195597.xml · nonDerivative · entry 1 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,674,206 F1 · shares: Represents tax withholding upon the vesting of 7,100 shares of restricted stock on February 26, 2023. F2 · price: The closing price on February 24, 2023 of the Company's common stock on NASDAQ. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 23:39 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
Tax withholdingCommon Stock | 4,350 | $78.46 | $341,301.00 |
DisclosureSEC source: 0001298709-23-000013 · wf-form4_167762753740439.xml · nonDerivative · entry 1 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,734,338 F1 · shares: Represents tax withholding upon the vesting of 10,200 shares of restricted stock on February 26, 2023. F2 · price: The closing price on February 24, 2023 of the Company's common stock on NASDAQ. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 22:44 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 803 | $81.56 | $65,492.04 |
DisclosureSEC source: 0001298711-23-000006 · wf-form4_167416827258921.xml · nonDerivative · entry 10 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,738,688 F5 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share. F6 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F9 · price: The transaction was executed in multiple trades ranging from $81.3700 to $81.9200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F7 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 22:44 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 2,048 | $80.75 | $165,382.35 |
DisclosureSEC source: 0001298711-23-000006 · wf-form4_167416827258921.xml · nonDerivative · entry 9 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,739,491 F5 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share. F6 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan. F8 · price: The transaction was executed in multiple trades ranging from $80.3500 to $81.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F7 · ownership.nature: Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 22:44 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 804 | $81.56 | $65,573.60 |
DisclosureSEC source: 0001298711-23-000006 · wf-form4_167416827258921.xml · nonDerivative · entry 8 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,677,263 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share. F9 · price: The transaction was executed in multiple trades ranging from $81.3700 to $81.9200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 22:44 UTC |
Krishnan SumaDirector · President, R&D · 10% owner
|
SaleCommon Stock | 2,048 | $80.75 | $165,381.53 |
DisclosureSEC source: 0001298711-23-000006 · wf-form4_167416827258921.xml · nonDerivative · entry 7 Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,678,067 F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share. F8 · price: The transaction was executed in multiple trades ranging from $80.3500 to $81.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 22:43 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 804 | $81.56 | $65,573.60 |
DisclosureSEC source: 0001298709-23-000006 · wf-form4_167416818123463.xml · nonDerivative · entry 10 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,677,263 F5 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share. F6 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F9 · price: The transaction was executed in multiple trades ranging from $81.3700 to $81.9200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F7 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 22:43 UTC |
Krishnan Krish SDirector · President and CEO · 10% owner
|
SaleCommon Stock | 2,048 | $80.75 | $165,381.53 |
DisclosureSEC source: 0001298709-23-000006 · wf-form4_167416818123463.xml · nonDerivative · entry 9 Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,678,067 F5 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share. F6 · shares: These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma Krishnan. F8 · price: The transaction was executed in multiple trades ranging from $80.3500 to $81.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. F7 · ownership.nature: Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.